Figure 1

Baseline, 6 month and 12 month LVEF for each patient in DFO monotherapy and DFP combination arms. With DFP combination, mean LVEF increased from 49.9% to 55.2% at 6 months (n = 10) and to 58.3% at 12 months (n = 7): with monotherapy LVEF increased from 52.8% to 55.7% at 6 months (n = 6) and to 56.9% at 12 months (n = 4). The improvements are significant over time in both arms (p = 0.04) but without significant difference between arms (p = 0.86 for treatment; p = 0.89 for the interaction).